SunWay Biotech Co., LTD. (TPEX:1271)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
66.00
-1.00 (-1.49%)
Apr 2, 2025, 1:50 PM CST
-45.21%
Market Cap 4.05B
Revenue (ttm) 810.99M
Net Income (ttm) 99.60M
Shares Out 60.39M
EPS (ttm) 1.99
PE Ratio 33.71
Forward PE n/a
Dividend 0.98 (1.50%)
Ex-Dividend Date Apr 11, 2024
Volume 111,136
Average Volume 68,800
Open 66.40
Previous Close 67.00
Day's Range 65.20 - 68.30
52-Week Range 65.50 - 130.31
Beta -0.14
RSI 37.90
Earnings Date Mar 20, 2025

About SunWay Biotech Co., LTD.

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan. [Read more]

Industry Packaged Foods
Founded 2007
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1271
Full Company Profile

Financial Performance

In 2023, SunWay Biotech Co., LTD.'s revenue was 571.11 million, an increase of 34.27% compared to the previous year's 425.35 million. Earnings were 44.08 million, an increase of 46.71%.

Financial Statements

News

There is no news available yet.